Led by Allison Page, NP-C, our highly skilled Nurse Practitioner with over 20 years of healthcare experience, we combine medical expertise with an artistic eye to deliver natural, beautiful results that enhance not alter your appearance
Zuyi Yang, orcid.org/0009-0000-3317-4136
We previously examined GLP-1 dispensing and prescribing patterns immediately following the July 2025 CVS formulary change and found that switching from AOM tirzepatide increased more than 16-fold in July, with most patients transitioning to AOM semaglutide
We believe access to effective weight loss treatment should not be hindered by cost
7, 2025 Journal of Obesity, A Comprehensive Review on Weight Gain following Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists for Obesity, May 10, 2024 KFF, Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford, Nov
Quality Control : Unlike FDA-approved medications, compounded drugs dont undergo the same rigorous testing for purity, potency, and sterility
